Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
BIOVF
27.00%
▲ 15.89%
CSPCY
12.98%
▼ -47.51%
Gross Margin
BIOVF
76.68%
▲ 0.98%
CSPCY
76.15%
▲ 10.59%
Free Cash Flow
BIOVF
$167.88M
▲ $72.37M
CSPCY
$0.00
▼ -$280.77M
Net Debt / EBITDA
BIOVF
1.30
▼ -0.27
CSPCY
-1.15
▼ -0.47
Operating Margin
BIOVF
26.41%
▲ 0.40%
CSPCY
39.51%
▲ 28.50%
P/E Ratio
BIOVF
171.97
▼ -91.76
CSPCY
—